281 results on '"Felker, G"'
Search Results
2. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
3. Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
4. The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF
5. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
6. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
7. Managing Obesity in Heart Failure
8. Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure
9. Blood Volume Analysis-Guided Heart Failure Management
10. Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study
11. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial
12. Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways
13. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
14. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
15. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
16. Electronic Health Record Characterization and Outcomes of Heart Failure with Preserved Ejection Fraction
17. Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure
18. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure
19. Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan
20. Medication-Attributable Adverse Events in Heart Failure Trials
21. WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION?
22. Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure
23. APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY
24. CHARACTERISTICS AND OUTCOMES OF TRIAL-ELIGIBLE VS INELIGIBLE PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
25. BEDSIDE RISK PREDICTION OF ADVERSE OUTCOMES IN MEDICALLY TREATED PATIENTS WITH SEVERE TRICUSPID REGURGITATION
26. ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL
27. Duration of Heart Failure, In-hospital Clinical Trajectory, and Postdischarge Outcomes in Patients Hospitalized for Heart Failure
28. Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan
29. Functional and Symptomatic Clinical Trial Endpoints
30. Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status
31. Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
32. A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes
33. Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction
34. Diaphragmatic Function in Cardiovascular Disease
35. Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients With Worsening Heart Failure
36. Are We Getting Any Closer to Understanding Congestion?
37. Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
38. Reply
39. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF
40. Electronic-based Characterization And Outcomes Of Heart Failure With Preserved Ejection Fraction
41. Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study
42. Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction
43. Natriuretic Peptides and Stratification for ICD Therapy in Nonischemic Heart Failure
44. THE EFFECT OF OMECAMTIV MECARBIL IN HOSPITALIZED PATIENTS AS COMPARED WITH OUTPATIENTS: A PRESPECIFIED ANALYSIS OF GALACTIC-HF
45. CLASSIFICATION AND IMPLICATIONS OF HEART FAILURE EVENTS FROM THE VICTORIA TRIAL
46. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
47. Leveraging Multiple Biomarkers to Assess Risk of Acute Heart Failure: Is More Better?
48. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
49. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
50. TCT-142 Clinical Outcomes Among Patients With Severe Tricuspid Valve Regurgitation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.